Single-agent MOR208 salvage and maintenance therapy in a patient with refractory/relapsing diffuse large B-cell lymphoma: a case report

Peer Review reports

Original Submission
6 Aug 2015	Submitted	Original manuscript
29 Feb 2016	Reviewed	Reviewer Report - Stephanie Elkins
14 Mar 2016	Author responded	Author comments - Wojciech Jurczak
Resubmission - Version 2
14 Mar 2016	Submitted	Manuscript version 2
Publishing
18 Mar 2016	Editorially accepted
14 May 2016	Article published	10.1186/s13256-016-0875-x

Back to article page